135680-78-3 Usage
General Description
"(2,5-dioxopyrrolidin-1-yl)oxyformic acid" is a chemical compound with a molecular formula C6H5NO5. It is also known as N-formylpiperidine-2,5-dione and is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. (2,5-dioxopyrrolidin-1-yl)oxyformic acid has various chemical and biological properties, making it useful in different applications. It is a white solid with a molecular weight of 163.1 g/mol and a melting point of around 115-118°C. The chemical structure of "(2,5-dioxopyrrolidin-1-yl)oxyformic acid" contains a pyrrolidin-2,5-dione core with a formyl group attached to the nitrogen atom. (2,5-dioxopyrrolidin-1-yl)oxyformic acid plays a significant role in organic chemistry and has potential industrial and research applications.
Check Digit Verification of cas no
The CAS Registry Mumber 135680-78-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,5,6,8 and 0 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 135680-78:
(8*1)+(7*3)+(6*5)+(5*6)+(4*8)+(3*0)+(2*7)+(1*8)=143
143 % 10 = 3
So 135680-78-3 is a valid CAS Registry Number.
InChI:InChI=1/C6H7NO7/c7-3(13-5(9)10)1-2-4(8)14-6(11)12/h7H,1-2H2,(H,9,10)(H,11,12)/p-1
135680-78-3Relevant articles and documents
Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity
-
, (2008/06/13)
Novel carbohydrate-based compounds with an attached ring system that have antimicrobial or cytostatic activity. The compounds are administered to humans and animals for the treatment or amelioration of bacterial, fungal, viral or protozoal infections or tumors. The compounds are of the general formula: 1
Glycosylated prodrugs, their method of preparation and their uses
-
, (2008/06/13)
Glycosylated prodrugs, a preparation method therefor, and their use with tumor-specific immunoenzymatic conjugates for the treatment of cancer, are described. These anthracycline prodrugs have formula (I). STR1
